DUBLIN--(BUSINESS WIRE)--Jul 13, 2018--The "Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The researcher announced the results of its Schizophrenia patients study in a new research, Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2018. The research provides insights into Schizophrenia epidemiology, Schizophrenia diagnosed patients, and Schizophrenia treatment rate for EU5 countries. The research measures key indicators including prevalence of Schizophrenia derived from epidemiological analysis, patients diagnosed with Schizophrenia, and patients treated with a drug therapy.

The research study helps executives estimate Schizophrenia market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Schizophrenia prevalence, Schizophrenia diagnosis rate, and Schizophrenia treatment rate for the period 2017 - 2026. The information is presented by EU5 countries including Germany, France, Spain, Italy, and UK.

Key Features of the Report:

Schizophrenia Patient Flow Schizophrenia Prevalence Schizophrenia Diagnosed Patients Schizophrenia Treated Patients

Key Topics Covered:

1. Schizophrenia: Disease Definition

2. Schizophrenia Patient Flow in Europe

3. Schizophrenia Patient Flow in Germany

4. Schizophrenia Patient Flow in France

5. Schizophrenia Patient Flow in Spain

6. Schizophrenia Patient Flow in Italy

7. Schizophrenia Patient Flow in UK

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/research/9kcz3k/europe?w=4

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

View source version on businesswire.com:https://www.businesswire.com/news/home/20180713005389/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Schizophrenia Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 07/13/2018 12:55 PM/DISC: 07/13/2018 12:55 PM